April 15, 2022 April 15, 2022Categories News in BriefNews in Brief, April 2022Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
August 17, 2021 August 17, 2021Categories Active Clinical TrialsNow Enrolling: EA8184 for Prostate CancerThis phase II study is testing the effects and safety of green tea catechins (GTC) as a chemopreventive agent
January 25, 2021 January 25, 2021Categories Active Clinical TrialsNow Enrolling: EA8183 / ERADICATE for Patients with Localized Prostate CancerThis phase III study, led by Dr. Alicia Morgans, is exploring a new treatment option for patients with prostate cancer with high-risk features
December 14, 2020 December 14, 2020Categories Active Clinical TrialsNow Enrolling: ECOG-ACRIN Opened Five New Trials in OctoberThe five phase III trials span different cancer types: prostate, leukemia, anal, lung, and myeloma